References:
1. Nair S, Swerdlow C. Monitoring for and Diagnosis of Lead Dysfunction.
Card Electrophysiol Clin. 2018;10(4):573–599.
2. Leong D, van Erven L. Unrecognized failure of a narrow caliber
defibrillation lead: the role of defibrillation threshold testing in
identifying an unprotected individual. Pacing Clin Electrophysiol.
2012;35(6):e154–e155.
3. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S,
Seidl K. (2007, May 15). Annual Rate of Transvenous Defibrillation Lead
Defects in Implantable Cardioverter-Defibrillators Over a Period of 10
Years. Circulation, 115(19), 2474-2480.
4. Mizobuchi M, Enjoji Y. Successful detection of a high-energy
electrical short circuit and a “rescue” shock using a novel automatic
shocking-vector adjustment algorithm. Heart Rhythm Case Rep
2015;1:27-30.
5. US Food and Drug Administration. FDA Classifies Voluntary Physician
Advisory Letter on Riata and Riata ST Silicone Defibrillation Leads as
Class I Recall (Urgent Medical Device Advisory); 2011.
6. Chung R, Garrett P, Wisnoskey B, Bhargava M, Wilkoff B. Clinical
implications of real time implantable cardioverter-defibrillator high
voltage lead short circuit detection. Int J Heart Rhythm 2017;2:49-51.